Author:
Nair Girish B.,Niederman Michael S.
Subject
Pharmacology (medical),Pharmacology
Reference104 articles.
1. Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)
2. Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance;Adrie;Crit. Care,2013
3. Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial;Alexander;JAMA.,2019
4. International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia. [Research Support, U.S. Gov’t, Non-P.H.S.];Aliberti;J. Inf. Secur.,2019
5. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. [Multicenter Study Observational Study];Aliberti;Lancet Infect. Dis.,2016
Cited by
85 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献